PIM
BIIB icon

Progressive Investment Management’s Biogen BIIB Stock Holding History

Progressive Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,255
Closed -$384K – 63
2015
Q4 		$384K Hold
1,255
– – 0.41% 57
2015
Q3 		$366K Sell
1,255
-12
-0.9% -$3.96K 0.42% 58
2015
Q2 		$512K Sell
1,267
-33
-3% -$13.2K 0.56% 46
2015
Q1 		$548K Sell
1,300
-21,053
-94% -$8.3M 1.89% 28
2014
Q4 		$7.59M Buy
22,353
+355
+2% +$115K 2.6% 18
2014
Q3 		$7.28M Sell
21,998
-48
-0.2% -$15.8K 2.52% 19
2014
Q2 		$6.95M Buy
22,046
+22,025
+104,881% +$6.63M 2.24% 30
2014
Q1 		$6K Hold
21
– – ﹤0.01% 49
2013
Q4 		$6K Buy
+21
New +$5.43K ﹤0.01% 54

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Progressive Investment Management's BIIB Position: Q1 2016 in Review

Progressive Investment Management sold out of Biogen (BIIB) in Q1 2016, closing a stake of 1,255 shares — an estimated $384K sold.

Progressive Investment Management first reported a position in BIIB in Q4 2013 and held it in 9 quarters. The position peaked at $7.59M in Q4 2014. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Progressive Investment Management reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Progressive Investment Management sold 1,255 Biogen shares in Q1 2016, an estimated $384K.
  • Progressive Investment Management first reported a position in Biogen in Q4 2013 and held it in 9 quarters.
  • Progressive Investment Management's Biogen position peaked at $7.59M in Q4 2014.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Progressive Investment Management's 13F filing for Q1 2016, filed 13 May 2016.